{"filing":{"accession_number":"0001193125-26-248246","cik":"0001746466","ticker":"EQ","company_name":"Equillium, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"d148127d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1746466/000119312526248246/d148127d8k.htm"},"events":[{"id":8116,"run_id":7124,"accession_number":"0001193125-26-248246","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure of shareholder vote results from Equillium's 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes on four proposals: election of directors (with Peter Colabuono not renominated and board size reduced from seven to six), approval of a reverse stock split authorization (1-for-2 to 1-for-20 ratio at board discretion), ratification of Crowe LLP as independent auditor, and approval to increase authorized common shares from 200 million to 400 million. These results are material to investors as they reflect shareholder decisions on governance, capital structure, and audit oversight.","company_name":"Equillium, Inc.","ticker":"EQ","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2710,"accession_number":"0001193125-26-248246","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Equillium's 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes on four proposals: election of directors (with Peter Colabuono not renominated and board size reduced from seven to six), approval of a reverse stock split authorization (1-for-2 to 1-for-20 ratio at board discretion), ratification of Crowe LLP as independent auditor, and approval to increase authorized common shares from 200 million to 400 million. These results are material to investors as they reflect shareholder decisions on governance, capital structure, and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:13:16.399080+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2710,"accession_number":"0001193125-26-248246","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Equillium's 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes on four proposals: election of directors (with Peter Colabuono not renominated and board size reduced from seven to six), approval of a reverse stock split authorization (1-for-2 to 1-for-20 ratio at board discretion), ratification of Crowe LLP as independent auditor, and approval to increase authorized common shares from 200 million to 400 million. These results are material to investors as they reflect shareholder decisions on governance, capital structure, and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:13:16.399080+00:00","company_name":"Equillium, Inc.","ticker":"EQ","filing_date":"2026-05-29"}]}